{
    "Trade/Device Name(s)": [
        "CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel",
        "CDC Flu rRT-PCR Dx Panel"
    ],
    "Submitter Information": "Centers for Disease Control and Prevention",
    "510(k) Number": "K111507",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080570",
        "K101564"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OQW",
        "NXD",
        "OEP",
        "NSU"
    ],
    "Summary Letter Date": "August 23, 2011",
    "Summary Letter Received Date": "June 1, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3332"
    ],
    "Regulation Name(s)": [
        "Reagents for detection of specific novel influenza A viruses"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A virus",
        "Influenza B virus",
        "Influenza A/H1",
        "Influenza A/H3",
        "Influenza A/H1pdm09",
        "Influenza A/H5 (Asian Lineage)"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swabs",
        "Nasal swabs",
        "Throat swabs",
        "Nasal aspirates",
        "Nasal washes",
        "Dual nasopharyngeal/throat swabs",
        "Bronchoalveolar lavage",
        "Bronchial wash",
        "Tracheal aspirate",
        "Sputum",
        "Lung tissue",
        "Viral culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time RT-PCR",
        "Oligonucleotide primer/probe hydrolysis assay"
    ],
    "Methodologies": [
        "RT-PCR",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Panel",
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel for qualitative detection, characterization, and surveillance of influenza A and B viruses and subtypes using RT-PCR.",
    "Indications for Use Summary": "For qualitative detection and characterization of influenza A and B viral RNA and subtyping (A/H1, A/H3, A/H1pdm09, A/H5) from human respiratory specimens and viral culture, and for epidemiologic surveillance, using real-time RT-PCR in conjunction with clinical and epidemiological information.",
    "fda_folder": "Microbiology"
}